… but compelling evidence supporting the potential cardiovascular benefits of ROCK
inhibition in preclinical animal disease models and in the clinic. This review summarises the …

… Hence, we argue strongly for translational medical research focused on evaluating the
human … Other possible clinical implications of HDACs, such as fibrotic complications of CD or …

… Preclinical and clinical data have suggested a potential synergism between radiation therapy
and immunotherapy. Indeed, ionizing radiations might increase antigen release from dying …

… and effective biomarkers and therapeutic targets for CVDs are urgently needed. … potential
therapeutic target for CVDs and the miRNA-based therapeutic approaches to perform in clinical …

… of lysosomes, their potential role in the pathophysiology of malignant disease and consider
why lysosomes might represent a good therapeutic target for acute myeloid leukemia (AML). …

… Broadly expressed transcription factors are considered unsuitable therapeutic targets
since their inactivation or downregulation could be detrimental to organism homoeostasis. …

… that the effects are mediated by ribozyme cleavage of the target RNA. … hammerhead
ribozymes has considerable therapeutic potential. … Potential therapeutic targets for angiogenesis …

… of concomitantly decreasing body weight while enhancing insulin action that does not
induce adverse side effects such as those described above would have broad clinical impact. …

… Their role as potential therapeutic targets … therapeutic targets, and the overwhelming message
is that “anti-cytokine medicine” is a rapidly growing field with major pharmaceutical impact. …

… as a therapeutic target. We also discussed a comprehensive study of Bcl-2 inhibitors as a
therapeutic target for cancer therapy. This investigation summarizes the potential of Bcl-2-…